VivoSeq
Other

Jet Lag

2

Pipeline Programs↗

0

Active Trials↗

4

Companies Involved↗

Jet Lag is an early-stage landscape with 2 programs across 4 companies. The most active players are Pfizer's Upjohn has merged with Mylan to form Viatris Inc., Neurim Pharmaceuticals Ltd., Eli Lilly.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

6/100

Mech. Concentration

50/100

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

P

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

1 program

Phase 2N

Neurim Pharmaceuticals Ltd.

1 program

Phase 2Eli Lilly logo

Eli Lilly

1 program

Phase 2M

MiraxBioPharma

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical
No programs
Phase 1
No programs
Phase 22

Hydrocortisone

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.

Melatonin

Neurim Pharmaceuticals Ltd.

Phase 3
No programs
Approved
No programs

Analysis

Trial Status

2

clinical trials

Completed2 · 100%

Clinical Trials

Trial Activity

Double-blind, Randomized, Placebo-controlled Scientific Study of the Comparative Effectiveness of Fitoavia Dietary Supplement in People With Dyssynchrony Syndrome.
Completed·MMiraxBioPharma·Preclinical·NCT07695870·120 enrolled
The Effects of Hydrocortisone, Melatonin, and Placebo on Symptoms of Jet Lag
Completed·National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 2·NCT00097474·57 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)